Volume 25, Issue 6 (Iranian South Medical Journal 2023)
Iran South Med J 2023, 25(6): 489-504 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shahhosseini S, Zare M. Association of rs2787094 in ADAM33 and rs11650354 in TBX21 Gene Polymorphisms with Asthma in Iranian Patients. Iran South Med J 2023; 25 (6) :489-504
URL: http://ismj.bpums.ac.ir/article-1-1700-en.html
URL: http://ismj.bpums.ac.ir/article-1-1700-en.html
1- Department of Biology, School of Sciences, Payame Noor University, Shahre Rey, Iran
2- Department of Biology, School of Sciences, Payame Noor University, Tehran, Iran ,m_zare@pnu.ac.ir
2- Department of Biology, School of Sciences, Payame Noor University, Tehran, Iran ,
Abstract: (1326 Views)
Background: Asthma is a common inflammatory disease of the airways which is characterized by variable and recurrent symptomes. The disease causes airways inflamtion and hyperresponsiveness, reversible airways obstruction and airway deformity and accomponied with symptoms including shortness of breath, cough and wheezing in patients. Environmental and genetic factor such as gene polymorphisms are involved in the development of asthma. Gene polymorphisms alter the function of genes, hence they involve in disease progression. Studies have shown genetic polymorphism in ADAM33 and TBX21 genes are associated with the risk of asthma.
Materials and Methods: In present study the polymorphism rs2787094 of ADAM33 and rs11650354 of TBX21 genes was assessed for the first time in Iranian asthma patients and healthy individuals. For this purpose, 30 blood samples from asthma patients and 30 samples from healthy donors was collected. Then DNA was extracted, and subsequently ARMS-PCR technique was used, applying specific designed primers for normal and mutant allels for each polymorphism of candidate genes and then the results were analysed.
Results: The results indicated rs2787094 polymorphism in ADAM33 was significantly associated with the risk of asthma, while there was no significant relation between rs11650354 in TBX21 with asthma risk.
Conclusion: It seems that rs2787094 polymorphism in ADAM33 and different genotype in this locus play siginificant role in asthma risk in Iranian patients.
Materials and Methods: In present study the polymorphism rs2787094 of ADAM33 and rs11650354 of TBX21 genes was assessed for the first time in Iranian asthma patients and healthy individuals. For this purpose, 30 blood samples from asthma patients and 30 samples from healthy donors was collected. Then DNA was extracted, and subsequently ARMS-PCR technique was used, applying specific designed primers for normal and mutant allels for each polymorphism of candidate genes and then the results were analysed.
Results: The results indicated rs2787094 polymorphism in ADAM33 was significantly associated with the risk of asthma, while there was no significant relation between rs11650354 in TBX21 with asthma risk.
Conclusion: It seems that rs2787094 polymorphism in ADAM33 and different genotype in this locus play siginificant role in asthma risk in Iranian patients.
Type of Study: Original |
Subject:
medical Genetics
Received: 2023/01/10 | Accepted: 2023/03/7 | Published: 2023/07/4
Received: 2023/01/10 | Accepted: 2023/03/7 | Published: 2023/07/4
References
1. Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract 2017; 3: 1. [DOI]
2. Patadia MO, Murrill LL, Corey J. Asthma: symptoms and presentation. Otolaryngol Clin North Am 2014; 47(1): 23-32. [DOI]
3. Li Hf, Yan Lp, Wang K, et al. Association between ADAM33 polymorphisms and asthma risk: a systematic review and meta-analysis. Respir Res 2019; 20(1): 38. [DOI]
4. Fuchs O, Bahmer T, Rabe KF, et al. Asthma transition from childhood into adulthood. Lancet Respir Med 2017; 5(3): 224-34. [DOI]
5. Martinez FD. Genes, environments, development and asthma: a reappraisal. Eur Respir J 2007; 29(1): 179-84. [DOI]
6. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 2006; 7(2): 95-100. [DOI]
7. Lu KD, Forno E. Exercise and lifestyle changes in pediatric asthma. Curr Opin Pulm Med 2020; 26(1): 103-111. [DOI]
8. Molarius A, Hasselgren M. Socioeconomic status, lifestyle factors and asthma prevalence: results from a population-based study in Sweden. Scand J Public Health 2021: 14034948211060821. [DOI]
9. Backman H, Räisänen P, Hedman L, et al. Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016-results from three population surveys. Clin Exp Allergy 2017; 47(11): 1426-1435. [DOI]
10. Stern J, Pier J, Litonjua AA. Asthma epidemiology and risk factors. Semin Immunopathol 2020; 42(1): 5-15. [DOI]
11. Song P, Adeloye D, Salim H, et al. Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study. J Glob Health 2022; 12: 04052. [DOI]
12. Al Huneiti R, Saeed B, Nusr R, et al. National clinical guidelines: The diagnosis and management of asthma in adults. Qatar Med J 2022; 2022(2): 12. [DOI]
13. Lopert A, Rijavec M, Žavbi M, et al. Asthma treatment outcome in adults is associated with rs9910408 in TBX21 gene. Sci Rep 2013; 3: 2915. [DOI]
14. Robert F, Pelletier J. Exploring the Impact of Single-Nucleotide Polymorphisms on Translation. Front Genet 2018; 9: 507. [DOI]
15. Shastry BS. SNPs: impact on gene function and phenotype. Methods Mol Biol 2009; 578: 3-22. [DOI]
16. Shi F, Zhang Y, Qiu C. Gene polymorphisms in asthma: a narrative review. Ann Transl Med 2022; 10(12): 711. [DOI]
17. Ranjbar M, Whetstone CE, Omer H, et al. The Genetic Factors of the Airway Epithelium Associated with the Pathology of Asthma. Genes (Basel) 2022; 13(10): 1870. [DOI]
18. Van Eerdewegh P, Little RD, Dupuis J, et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002; 418(6896): 426-30. [DOI]
19. Tripathi P, Awasthi S, Gao P. ADAM Metallopeptidase Domain 33 (ADAM33): A Promising Target for Asthma. Mediators Inflamm 2014; 2014: 572025. [DOI]
20. Holgate ST, Davies DE, Powell RM, et al. ADAM33: a newly identified gene in the pathogenesis of asthma. Immunol Allergy Clin North Am 2005; 25(4): 655-68. [DOI]
21. Tripathi P, Awasthi S, Husain N, et al. Increased expression of ADAM33 protein in asthmatic patients as compared to non-asthmatic controls. Indian J Med Res 2013; 137(3): 507-14. [PubMed]
22. Munthe-Kaas MC, Carlsen KH, Håland G, et al. T cell-specific T-box transcription factor haplotype is associated with allergic asthma in children. J Allergy Clin Immunol 2008; 121(1): 51-6. [DOI]
23. Yong J, Chen GQ, Huang B, et al. Correlation between the ratio of T-bet/GATA-3 and the levels of IL-4 and IFN-γ in patients with allergic asthma. Mol Med Rep 2011; 4(4): 663-666. [DOI]
24. Dong L, Chen M, Zhang Q, et al. Tbet/GATA-3 ratio is a surrogate measure of Th1/Th2 cytokine profiles and may be novel targets for CpG ODN treatment in asthma patients. Chin Med J (Engl) 2006; 119(16): 1396-1399. [DOI]
25. Sharma N, Jaiswal I, Mandal RK, et al. Genetic variation of TBX21 gene increases risk of asthma and its severity in Indian children. J Hum Genet 2014; 59(8): 437-43. [DOI]
26. Tantisira KG, Hwang ES, Raby BA, et al. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl Acad Sci U S A 2004; 101(52): 18099-104. [DOI]
27. Abedian kenari S, Rafat manesh A, Aftabi Y, et al. Evaluation of IL-4 and IFN-γ levels in cell culture supernatant of allergic asthma patients. Iran South Med J 2016; 19(3): 342-350. (Persian) [DOI]
28. Zhao Sh, Shen W, Yu J, et al. TBX21 predicts prognosis of patients and drives cancer stem cell maintenance via the TBX21–IL-4 pathway in lung adenocarcinoma. Stem Cell Res Ther 2018; 9(1): 89. [DOI]
29. Ye YM, Lee HY, Kim SH, et al. Pharmacogenetic study of the effects of NK2R G231E G>A and TBX21 H33Q C>G polymorphisms on asthma control with inhaled corticosteroid treatment. J Clin Pharm Ther 2009; 34(6): 693-701. [DOI]
30. Ruan Z, Shi Z, Zhang G, et al. Asthma susceptible genes in children: A meta-analysis. Medicine (Baltimore) 2020; 99(45): e23051. [DOI]
31. Lee JH , Park HS, Park SW, et al. ADAM33 polymorphism: association with bronchial hyper-responsiveness in Korean asthmatics. Clin Exp Allergy 2004; 34(6): 860-5. [DOI]
32. Foley SC, Mogas AK, Olivenstein R, et al. Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol 2007; 119(4): 863-71. [DOI]
33. Zand Karimi MR, Faridhosseini R, Abbaszadegan MR, et al. Association of ADAM33 gene polymorphisms with allergic asthma. Iran J Basic Med Sci 2014; 17(9): 716-21. [PubMed]
34. Deng R, Zhao F, Zhong X. T1 polymorphism in a disintegrin and metalloproteinase 33 (ADAM33) gene may contribute to the risk of childhood asthma in Asians. Inflamm Res 2017; 66(5): 413-424. [DOI]
35. Zheng W, Wang L, Su X, et al. Association between V4 polymorphism in the ADAM33 gene and asthma risk: a meta-analysis. Genet Mol Res 2015; 14(1): 989-99. [DOI]
36. Zhu S, Li P, Suo H, et al. Association of ADAM33 gene polymorphisms with asthma in Mongolian and Han groups in Inner Mongolia. Saudi J Biol Sci 2018; 25(8): 1795-1799. [DOI]
37. Shirzad H, Meshkat R, Gangalikhani-Hakemi M, et al. Association Analysis of T-Cell Immunoglobulin and Mucin 1 Gene 5383-5397 Insertion/Deletion Polymorphism with Asthma and Total Serum Immunoglobulin E Levels in Patients with Asthma and Control. J Isfahan Med Sch 2014; 32(300): 1-10. [Article]
38. Sadri M, Ganjalikhani-Hakemi M, Salehi R, et al. Prevalence of TIM-3 Gene Polymorphisms in Patients with Asthma and its correlation with Serum Levels of Immunoglobulin-E of These Patients in Isfahan, Iran. J Isfahan Med Sch 2015; 32(314): 2193-2201. (Persian) [Article]
39. Nadi E, Hajilooei M, Roshani M, et al. Analysis of HPA-1 polymorphism in patients with bronchial asthma. Yafteh 2007; 8(2): 61-69. (Persian) [Article]
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
